Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
Loading
Income Tax Expense Over TimeContracting
Percentile Rank67
3Y CAGR-61.0%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
-61.0%/yr
Annual compound
Percentile
P67
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$46000.00+111.7%
2024$-393000.00-107.8%
2023$5.03M+549.4%
2022$774000.00-
2021$0.00-
2020$0.00-
2019$0.00-